Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

ETR/2HQ0 stock hub

ETR/2HQ0 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

ETR/2HQ0is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
563.5M
Deutsche Börse Xetra
Market data

Live price

Current market quote for this ticker.

Current price
ETR/2HQ0
In the news

Latest news · ETR/2HQ0

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E11
P25 12.3P50 15.7P75 20.2
Trailing P/En/a
P25 16.4P50 20.9P75 30.4
ROE-63.2
P25 -6.7P50 8.5P75 17.2
ROIC-4
P25 -1.7P50 8.5P75 17.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All ETR/2HQ0 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
171
Groups with data
11
Currency
USD
Showing 171 of 171 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
United States
Country code
DE
Employees
2,842
Employees Change
192%
Employees Change Percent
7.25
Enterprise value
EUR 619M
Exchange
Deutsche Börse Xetra
Financial currency
USD
First seen
2026-05-10
Industry
Drug Manufacturers - Specialty & Generic
Isin
US88688T2096
Last refreshed
2026-05-10
Market cap
EUR 563.5M
Price
EUR 4.67
Price currency
EUR
Rev Per Employee
255,579.92x
Sector
Healthcare
Sic
2834
Symbol
etr/2HQ0
Website
https://www.tilray.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

9
MetricValue
Earnings Yield
-201.96%
EV Earnings
-0.54x
EV/EBITDA
34.64x
EV/FCF
-9.91x
EV/Sales
0.85x
FCF yield
-11.08%
Forward P/E
10.96x
P/B ratio
0.44x
P/S ratio
0.78x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

21
MetricValue
EBIT Margin
-7.52%
EBITDA Margin
2.07%
Gross margin
27.68%
Gross Profit
EUR 201M
Gross Profit Growth
-7.59%
Gross Profit Growth Q
5.54%
Gross Profit Growth3 Y
44.64%
Gross Profit Growth5 Y
23.44%
Net Income
EUR -1.1B
Net Income Growth Quarters
1%
Net Income Growth Years
0%
Pretax Margin
-169.76%
Profit Margin
-156.67%
Profit Per Employee
EUR -400,405
ROA
-1.47
Roa5y
-1.87
ROCE
-3.55
ROE
-63.16
Roe5y
-30.72
ROIC
-4.04
Roic5y
-3.64

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

8
MetricValue
EPS Growth Quarters
1
EPS Growth Years
0
Revenue Growth
3.83x
Revenue Growth Q
11.28x
Revenue Growth Quarters
1x
Revenue Growth Years
2x
Revenue Growth3 Y
12.91x
Revenue Growth5 Y
12.89x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

21
MetricValue
Asset Turnover
EUR 0.31
Assets
EUR 1.8B
Cash
EUR 186.1M
Current Assets
EUR 609.5M
Current Liabilities
EUR 218.4M
Debt
EUR 268.3M
Debt EBITDA
EUR 15.07
Debt Equity
EUR 0.21
Debt FCF
EUR -4.3
Equity
EUR 1.3B
Interest Coverage
-1.99
Liabilities
EUR 464.7M
Long Term Assets
EUR 1.1B
Long Term Liabilities
EUR 246.3M
Net Cash
EUR -82.2M
Net Cash By Market Cap
EUR -14.59
Net Debt EBITDA
EUR 5.47
Net Debt Equity
EUR 0.06
Tangible Book Value
EUR 661.5M
Tangible Book Value Per Share
EUR 5.69
WACC
13.33

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
2.79
Inventory Turnover
2.23
Net Working Capital
EUR 232.6M
Quick ratio
1.31
Working Capital
EUR 390.3M
Working Capital Turnover
EUR 1.64

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-26.41%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

29
MetricValue
50-day SMA
5.81
All Time High
13.2
All Time High Change
-64.62%
All Time High Date
2025-12-18
All Time Low
4.67
All Time Low Change
0%
All Time Low Date
2026-05-08
ATR
0.34
Beta
2.11
Ch YTD
-40.68
High
4.87
High52
13.2
High52 Date
2025-12-18
High52ch
-64.62%
Low
4.67
Low52
4.67
Low52 Date
2026-05-08
Low52ch
0%
Ma50ch
-19.65%
RSI
32.87
RSI Monthly
0
RSI Weekly
39.07
Sharpe ratio
-0.35x
Sortino ratio
-0.51
Total Return
-26.41%
Tr YTD
-40.68
Tr1m
-16.76%
Tr1w
-8.43%
Tr3m
-26.11%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
EUR -54.7M
Operating margin
-7.52

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
118,367,051%
Net Borrowing
-13,456,309
Shares Insiders
0.77%
Shares Institutions
7.62%
Shares Qo Q
2.11%
Shares Yo Y
26.41%
Short Ratio
3.28

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

47
MetricValue
Adjusted FCF
EUR -93.9M
Average Volume
8,992.65x
Bv Per Share
11.34
CAPEX
EUR -24.7M
Ch1m
-16.76
Ch1w
-8.43
Ch3m
-26.11
Change
-2.51%
Change From Open
-2.51
Close
4.79
Days Gap
0
Depreciation Amortization
69,821,191.1
Dollar Volume
46,905.5
Earnings Date
2026-07-24
EBIT
EUR -54.7M
EBITDA
EUR 15M
EPS
EUR -10.68
F Score
4
FCF
EUR -62.5M
FCF EV Yield
-10.09x
Financing CF
67,248,691
Fiscal Year End
May
Goodwill
637,964,210.7
Income Tax
EUR -103.2M
Investing CF
7,532,070
Is Primary Listing
0
Last Earnings Date
2026-04-01
Last Report Date
2026-02-28
Last Split Date
2025-12-02
Last Split Type
Reverse
Ma20
5.58
Ma20ch
-16.35%
Net CF
41,933,319
Next Earnings Date
2026-07-24
Open
4.79
Position In Range
0
Ppne
475,661,740
Price Date
2026-05-08
Price EBITDA
EUR 37.49
Ptbv Ratio
0.85
Relative Volume
1.15x
Revenue
726,358,133x
SBC By Revenue
4.33x
Share Based Comp
31,448,508
Tax By Revenue
-14.2x
Volume
10,044
Z Score
-1.72
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does ETR/2HQ0 pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns ETR/2HQ0?

Insider, institutional, and short-interest positioning.

Institutional ownership
+7.6%
Share of float held by funds and institutions
Insider ownership
+0.8%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
3.3 days to cover
Y/Y dilution
+26.4%
Negative means the company is buying back shares.
Technical

ETR/2HQ0 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
32.9
Neutral momentum band
Price vs 200-day MA
n/a
50/200-day relationship not available
Beta (5Y)
2.11
More volatile than the market
Sharpe ratio
-0.35
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About ETR/2HQ0

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/2HQ0 stock rating?

etr/2HQ0 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/2HQ0 analysis?

The full report lives at /stocks/etr/2HQ0/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/2HQ0?

The latest report frames etr/2HQ0 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/2HQ0 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.